A research team led by Minyoung Lee and Sunggyu Park of The Korea Institute of Materials Science (KIMS) Bio & Health ...

CareDx completed the sale of its lab products business to Eurobio Scientific on June 30, 2026, and received $171.2 million in ...

CareDx CDNA recently completed the acquisition of Naveris, expanding its presence in high-growth specialty oncology. The ...

EUROBIO SCIENTIFIC FINALIZES THE ACQUISITION OF CAREDX’s TRANSPLANT LAB PRODUCT DIVISION Acceleration of Eurobio’s strategic ...

The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant ...

The detection and characterization of human leukocyte antigen (HLA) antibodies are central to assessing immunological risk in transplantation. While conventional HLA antibody testing has traditionally ...

Members of the HLA’s Horticulture Crops Weed Science Lab recently published three peer-reviewed research articles. Greenhouse evaluation of napropamide and pendimethalin for suppression of strawberry ...

According to MarketsandMarkets, the Transplant Diagnostics Market is projected to grow from about USD 5.61 billion in 2026 to USD 8.14 billion ...

The Federal Communications Commission (FCC) is set to ban a China-based “bad lab” for providing false equipment test results, continuing the government agency’s push toward weeding out network ...

CHICAGO (WLS) -- A prominent lab used by prosecutors for marijuana DUI testing in Chicago and the suburbs is no longer doing human testing but the fallout surrounding the flawed results continues.

Background The diagnostic and prognostic relevance of Human Leukocyte Antigen B-27 (HLA-B27) in Axial Spondyloarthritis (AxSpA) is undeniable, with 70% of Ankylosing Spondylitis (AS) patients carrying ...